Back to Search
Start Over
Gilead, Arcus announce data supporting ongoing Phase 3 STAR-221 study
- Source :
- The Fly. June 2, 2024
- Publication Year :
- 2024
-
Abstract
- Gilead Sciences (GILD) and Arcus Biosciences (RCUS) announced longer-term efficacy and safety results from Arm A1 of the Phase 2 EDGE-Gastric study. These updated data show consistent objective response rate [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.796066618